Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01943513 | A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers | PHASE1 | COMPLETED | 34 | — | — | Oct 1, 2013 | May 1, 2014 | Sep 3, 2014 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| BIIB023 | EXPERIMENTAL | Participants receive intravenous (IV) infusions of BIIB023 |
| Placebo | PLACEBO_COMPARATOR | Participants receive intravenous (IV) infusions of placebo |
| Name | Type | Description |
|---|---|---|
| BIIB023 | BIOLOGICAL | Intravenous (IV) infusions |
| Placebo | BIOLOGICAL | Matched placebo |
Key Inclusion Criteria: * Deemed healthy as determined by the Investigator based on medical history, 12-lead electrocardiogram, vital signs, and clinical laboratory parameters at Screening, and physical examination at Baseline * Body mass index (BMI) between 18.5 and 32 kg/m2, inclusive, at the tim...